• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol . Transmission of SARS-CoV-2 between ferrets in presence of pre-existing immunity

tetano

Editor, Senior Moderator
J Virol


. 2025 Nov 4:e0156625.
doi: 10.1128/jvi.01566-25. Online ahead of print. Transmission of SARS-CoV-2 between ferrets in presence of pre-existing immunity

Chong Wang[SUP] #[/SUP][SUP] 1 2 [/SUP], Lei Shuai[SUP] #[/SUP][SUP] 1 2 [/SUP], Gongxun Zhong[SUP] #[/SUP][SUP] 1 2 [/SUP], Zhiyuan Wen[SUP] #[/SUP][SUP] 1 2 [/SUP], Renqiang Liu[SUP] 1 2 [/SUP], Qilong Liu[SUP] 1 [/SUP], Jinliang Wang[SUP] 1 2 [/SUP], Jinying Ge[SUP] 1 [/SUP], Xianfeng Zhang[SUP] 1 2 [/SUP], Yuntao Guan[SUP] 1 2 [/SUP], Xijun He[SUP] 1 2 [/SUP], Zhigao Bu[SUP] 1 2 3 [/SUP]



Affiliations
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of coronavirus disease 2019 (COVID-19), is characterized by its high contagiousness. The COVID-19 pandemic has exerted profound impacts on human society. The persistent circulation of SARS-CoV-2 in human populations continues to pose re-exposure risks for both vaccinated individuals and those with prior natural infection. Against this epidemiological background, there is an urgent need to characterize the transmission dynamics of SARS-CoV-2 in the context of pre-existing immunity. Using a ferret infection model, this study systematically addresses critical scientific questions, including viral transmission efficiency, temporal patterns of transmissibility, and the ability of pre-existing immunity to mitigate reinfection and viral shedding. The findings provide robust experimental evidence for elucidating the transmission mechanisms of SARS-CoV-2 and offer scientific insights to inform the rational design of optimized antiviral strategies.IMPORTANCEIn this study, a ferret infection model was used to systematically investigate SARS-CoV-2's in vivo transmission dynamics and modes with pre-existing immunity. By characterizing viral transmission efficiency, temporal shedding patterns, and immunity's role in mitigating re-infection severity and dissemination, it provides direct evidence for understanding SARS-CoV-2 spread in immune-exposed hosts. It quantifies how humoral immunity modulates viral load (primary/secondary infections) and ferret contact transmission. Findings establish a key SARS-CoV-2 transmission framework-pre-existing immunity shortens shedding, reduces secondary attack rates but retains residual transmissibility-fill knowledge gaps, guide vaccine/herd immunity/public health measures, and lay a foundation for predicting real-world transmission and antiviral policies via integrated endpoints.

Keywords: SARS-CoV-2; pre-existing immunity; transmission.

 
Back
Top Bottom